To amend title 18, United States Code, to prohibit former employees of covered health agencies from serving on the board of entities involved in development and research of a drug, biological product, or device and from profiting from a drug, biological product, or device, and for other purposes.
118th Congress
Introduced May 1, 2024
Sponsors
Legislative Progress
Introduced
Introduced
Committee
Passed
May 1, 2024
Mr. Vance introduced the following bill; which was read twice …
May 1, 2024
Mr. Vance introduced the following bill; which was read twice …
May 1, 2024
Mr. Vance introduced the following bill; which was read twice …
May 1, 2024
Mr. Vance introduced the following bill; which was read twice …
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology